Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Boston, Massachusetts 02114


Purpose:

The purpose of the study is to find out whether an experimental autologous dendritic cell vaccine is safe, well tolerated, and whether it can strengthen the immune system's response to HIV.


Criteria:

Inclusion Criteria: - HIV-1 positive - CD4+ T Cell count >200 - Undetectable HIV viral load for 6 months prior to screening - On antiretroviral treatment for 12 months prior to screening Exclusion Criteria: - Hepatitis C positive - Detectable HIV viral load within 6 months prior to study entry - Females who are pregnant or nursing


NCT ID:

NCT00833781


Primary Contact:

Principal Investigator
Rajesh Gandhi, MD
Massachusetts General Hospital


Backup Contact:

N/A


Location Contact:

Boston, Massachusetts 02114
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: October 09, 2019

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.